key: cord-0900269-0ul67eot authors: Chen, Hongguang; Zhang, Konglai title: Insight into impact of COVID-19 epidemic on tuberculosis burden in China date: 2020-07-30 journal: Eur Respir J DOI: 10.1183/13993003.02710-2020 sha: f228d4891d9d8ac00104e9b85261af475bca5646 doc_id: 900269 cord_uid: 0ul67eot COVID-19 and TUBERCULOSIS We are interested in an article published in the journal recently, entitled "The potential impact of COVID-19-related disruption on tuberculosis (TB) burden". The study used a mathematical model to estimate the relative impact of reductions in social contacts and health services on TB burden due to the COVID-19 epidemic. There included data and projections on China, being one of 22 high TB burden countries for both TB and multidrug resistant TB cases. COVID-19, which has spread rapidly and enveloped most of the world, is a unique global public health crisis for the century. By epidemic. In addition, there might be other interaction and causality deserved to be explored between COVID-19 and TB, such as whether the COVID-19 cases would boost the development of active TB, or vice versa. [7] [8] [9] It was also reported that COVID-19 had a modest impact on clinical symptoms and prognosis of anti-TB treatment in the short term but long-term impact still needed to be explored. [7] [8] In the long run, we do not think that the number of TB cases and deaths will increase as predicted by the model reported in McQuaid's study. 1 personal hygiene and protection including wearing masks in particular. In addition, the government is also taking this opportunity to further improve the public health infrastructure. The above measures will also enhance the capacity in diagnosis, treatment and management of TB patients so as to reduce the disease burden of TB. The potential impact of COVID-19-related disruption on tuberculosis burden National Health Commission. Overview of the epidemic situation of statutory infectious diseases in China National Health Commission. Overview of the epidemic situation of statutory infectious diseases in China in Feburary National Health Commission. Overview of the epidemic situation of statutory infectious diseases in China National Health Commission. Overview of the epidemic situation of statutory infectious diseases in China National Health Commission. Overview of the epidemic situation of statutory infectious diseases in China Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts Impact of COVID-19 on tuberculosis control in China The authors declare that they have no conflicts of interest to this paper. This research did not receive any specific grant from funding agencies from the public, commercial, or not-for-profit sectors. All authors certify that they have participated sufficiently in this work. Each author certifies that this material has not been submitted to or published in any other publication. All authors approved the final version of the manuscript.